CervoMed Inc. (CRVO) News
Track canonical SquawkNews coverage tagged to CRVO, CervoMed Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 14 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
CRVO - CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
CRVO - CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
NEWS | Sep 22, 2026, 11:30 AM UTC
L
CervoMed says Phase 2a nfvPPA biomarker data will be presented at ISFTD 2026
CervoMed said initial 12-week biomarker results from its Phase 2a nfvPPA trial will be presented as a late-breaking oral session at ISFTD 2026.
EQUITY | Sep 10, 2026, 08:16 PM UTC
H
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA
12-week biomarker data to be highlighted at the International Society of Frontotemporal Dementias (ISFTD) Annual MeetingnfvPPA, the type of frontotemporal dementia (FTD) most commonly associated with tau pathology, curre
EQUITY | Sep 10, 2026, 11:32 AM UTC
L
CervoMed Phase 2a results accepted for late-breaking ISFTD 2026 oral
EQUITY | Sep 10, 2026, 11:30 AM UTC
L
CRVO - CervoMed to Participate in September Investor Conferences
CRVO - CervoMed to Participate in September Investor Conferences
EQUITY | Sep 08, 2026, 11:30 AM UTC
H
UK Awards CRVO's Neflamapimod Innovation Passport
CRVO's Neflamapimod awarded UK innovation passport
EQUITY | Aug 04, 2026, 09:15 AM UTC
L
CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International
Latest findings on neflamapimod to be featured in presentations demonstrating its impact
EQUITY | Jul 06, 2026, 11:30 AM UTC
L
CDNL: Proposes Public Offering
CDNL proposes public offering of common stock
EQUITY | Jun 23, 2026, 09:24 AM UTC
M
CDNL: Proposes Public Offering
CDNL proposes public offering of common stock, among other equity offerings from various companies
EQUITY | Jun 22, 2026, 09:10 PM UTC
M
CRVO Raises $10M
CervoMed announces closing of $10 million registered direct offering of common stock priced at-the-market under Nasdaq rules
EQUITY | Jun 22, 2026, 08:05 PM UTC
M
12 Health Care Stocks Move
Twelve health care stocks are moving in Monday's pre-market session, with gains and losses across the sector
EQUITY | Jun 22, 2026, 12:08 PM UTC
M
CRVO Raises $10M
CervoMed agreed to raise $10M in a direct stock offering of 2.5M shares at $4/share to use for working capital
EQUITY | Jun 22, 2026, 10:15 AM UTC
M
CRVO Sells Shares
CRVO sells 2,500,000 shares of common stock at $4.00 per share
EQUITY | Jun 18, 2026, 04:36 PM UTC
M
CRVO: Offers $10M Common Stock
CervoMed announces $10 million registered direct offering of common stock priced at-the-market under Nasdaq rules
EQUITY | Jun 18, 2026, 04:35 PM UTC